Pierre A. Morgon

Dr. Pierre A. Morgon is a distinguished professional in the pharmaceutical and biotechnology sectors, currently serving as Co-Founder and Director at Anemos Therapeutics and Non Executive Director at both Lys Therapeutics and CanSino Biologics Switzerland SA. In addition, Dr. Morgon holds various leadership roles, including Chief Business Officer at Nuvamid and Chairman of the Board at Limula and Kupando GmbH. Their extensive experience also features membership on the Board of Trustees for The Global Centre for Risk and Innovation and other board positions that focus on governance and strategic initiatives. An academic with profound knowledge, Dr. Morgon earned a Doctorate of Pharmacy and multiple advanced degrees in law and business from esteemed institutions, positioning him as a leader in finance, governance, and partnership strategies within the industry.